AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Auctimet 850mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (850mg)

Overview Auctimet 850mg Tablet PR

Metformin 850mg tablets are prescribed for managing type 2 diabetes, effectively regulating blood glucose and mitigating associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize nausea or stomach upset, take Metformin 850mg with food, consistently at the same time daily. Discontinue use only under your physician's guidance. Maintaining a healthy lifestyle, including diet and exercise as directed by your doctor, is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, gas, fatigue, indigestion, abdominal discomfort, headache, and decreased appetite. Hypoglycemia (low blood sugar) may occur, especially when combined with other diabetes medications, alcohol, or missed meals; regular blood sugar monitoring is essential. Inform your doctor of any pre-existing kidney, liver, or heart conditions before starting treatment. Pregnant or nursing individuals require medical consultation prior to use. Kidney function tests will be assessed before commencing treatment. Limit alcohol consumption to reduce the potential for side effects.

Primary Ingredients of Auctimet 850mg Tablet PR

The information is unavailable.

Uses of Auctimet 850mg Tablet PR

Managing Type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Auctimet 850mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage information. Take each 850mg Auctimet PR tablet with a meal.

Common Side effects of Auctimet 850mg Tablet PR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Auctimet 850mg Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take each 850mg Auctimet PR tablet with a meal.

How Auctimet 850mg Tablet PR works:

Metformin 850mg tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Auctimet 850mg Tablet PR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Auctimet 850mg Tablet PR during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human studies remain scarce.

Breast feedingBreast feedingCAUTION

The use of Auctimet 850mg Tablets PR while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Auctimet 850mg Tablet PR, potentially requiring a modified dosage. Medical advice is essential. Auctimet 850mg Tablet PR is contraindicated for individuals with severely compromised kidney function.

LiverLiverUNSAFE

The use of Auctimet 850mg Tablet PR is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical guidance is recommended.

What if you forget to take Auctimet 850mg Tablet PR :

Should you forget to take your Auctimet 850mg Tablet PR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auctimet 850mg Tablet PR

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Auctimet 850mg Tablet PR

Individuals with type 2 diabetes exhibit impaired responsiveness to their own insulin. This leads to elevated blood glucose concentrations. Auctimet 850mg Tablet PR works through multiple mechanisms to lower these high blood sugar levels. The tablet reduces glucose production by the liver, diminishes glucose absorption from the intestines post-meal, and enhances the insulin sensitivity of bodily tissues. This facilitates improved glucose uptake from the bloodstream and improves the body's natural insulin response.
Auctimet 850mg Tablet PR has demonstrated a weight reduction effect in overweight and obese patients. This weight loss may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-initiation of Auctimet 850mg Tablet PR for weight management is strongly discouraged; physician consultation is mandatory.
Metformin 850mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and lessening intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 850mg extended-release, as monotherapy, infrequently leads to hypoglycemia due to its mechanism that avoids excessive insulin release. Beyond glycemic control, it also aids in mitigating weight increase.
Auctimet 850mg Tablet PR typically doesn't induce drowsiness and is generally well-received. Infrequently, though, it might lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Auctimet 850mg Tablet PR use.
Administer Auctimet 850mg Tablet PR with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily prescriptions, morning administration with breakfast is recommended. Twice-daily regimens should involve one tablet with breakfast and the second with dinner. For three daily doses, distribute them with breakfast, lunch, and dinner. Consuming Auctimet 850mg Tablet PR with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose levels. Auctimet 850mg Tablet PR works through multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Auctimet 850mg tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience similar weight reduction. However, self-medicating with this drug for weight management is strongly discouraged; always seek professional medical advice before initiating treatment.
Metformin 850mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and decreasing intestinal glucose absorption. Unlike some other oral hypoglycemics, Metformin 850mg extended-release, as monotherapy, infrequently leads to hypoglycemia due to its mechanism of action that avoids excessive pancreatic insulin release. Furthermore, it contributes to weight management.
The 850mg Auctimet PR tablet typically doesn't induce drowsiness and is generally well-received. Infrequently, though, it might lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Auctimet 850mg PR tablet use.
Administer Auctimet 850mg Tablet PR with or following a meal. The tablets should be swallowed whole with water; do not crush or chew them. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided into morning and evening doses, taken with breakfast and dinner respectively. Three times daily, distribute the doses among breakfast, lunch, and dinner. Ingesting Auctimet 850mg Tablet PR with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This results in elevated blood glucose concentrations. Auctimet 850mg Tablet PR manages hyperglycemia through multiple mechanisms. It reduces hepatic glucose production, limits intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. Consequently, glucose uptake from the bloodstream is improved, and the body's natural insulin response is optimized.
Auctimet 850mg tablets (PR) have demonstrated a weight-reducing effect in overweight and obese patients. This effect may also be observed, albeit modestly, in overweight and obese individuals with a predisposition to diabetes. Furthermore, insulin-resistant or insulin-sensitive individuals may experience weight loss. However, self-initiating this medication for weight management is inadvisable; physician consultation is mandatory.
Metformin 850mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication aids in blood glucose regulation by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, monotherapy with Metformin 850mg extended-release tablets infrequently leads to hypoglycemia due to its mechanism of action, which does not stimulate excessive insulin release from the pancreas. Beyond glycemic control, it also assists in managing weight.
Auctimet 850mg prolonged-release tablets generally do not induce drowsiness and are typically well-tolerated. Infrequently, however, Auctimet 850mg prolonged-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Consult your physician if fatigue or sleepiness develops during Auctimet 850mg prolonged-release tablet treatment.
Administer Auctimet 850mg Tablet PR with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily prescriptions, take the tablet in the morning with breakfast. Twice-daily prescriptions should be divided into morning and evening doses, taken with breakfast and dinner respectively. For thrice-daily regimens, administer doses with breakfast, lunch, and dinner. Consuming Auctimet 850mg Tablet PR with food mitigates potential gastrointestinal discomfort, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Auctimet 850mg Tablet PR
38
MRP 46
17% off